Thalidomide maintenance therapy maturates the T cell compartment and compromises antigen-specific antitumor immunity in patients with multiple myeloma. (Q50929024)
Jump to navigation
Jump to search
scientific article published on 8 November 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Thalidomide maintenance therapy maturates the T cell compartment and compromises antigen-specific antitumor immunity in patients with multiple myeloma. |
scientific article published on 8 November 2012 |
Statements
Thalidomide maintenance therapy maturates the T cell compartment and compromises antigen-specific antitumor immunity in patients with multiple myeloma. (English)
1 reference
Dirk Hose
1 reference
Hartmut Goldschmidt
1 reference
Isabelle Herth
1 reference
Philipp Beckhove
1 reference
Tobias Meissner
1 reference
Brigitte Neuber
1 reference
Melanie Engelhardt
1 reference
Jürgen Haas
1 reference
Kai Neben
1 reference
Anthony D Ho
1 reference
Bernard Klein
1 reference
Michael Hundemer
1 reference
8 November 2012
1 reference
41
1 reference
3
1 reference
231-240
1 reference